SEP 02, 2019 1:43 PM PDT

Standard Treatment Resistance Discovered in Crohn's Disease

WRITTEN BY: Nouran Amin

Researchers have mapped out more than 100,000 immune cells from biopsy samples of patients with Crohn's disease. The biopsy samples were retrieved from regions of inflamed and uninflamed Crohn's disease lesions on small intestine tissue and the analysis indicated a signature of cells implicated in the disease that does not respond to treatment. The discovery provides new clues to how we approach novel therapeutic options—findings were published in Cell.

Learn more about Crohn’s Disease:

"We designed this study in a way that defines inflammation with unprecedented precision using immunology and computational biology to get a better understanding of this disease," said co- corresponding author Judy H. Cho, MD, Senior Associate Dean for Precision Medicine, Director of The Charles Bronfman Institute for Personalized Medicine, Ward-Coleman Professor of Translational Genetics, and Professor of Medicine, and Genetics and Genomic Sciences, at the Icahn School of Medicine. "These results emphasize the limitations of current diagnostic assays and the potential for single-cell mapping tools to identify novel biomarkers for treatment response and tailored therapeutic opportunities."

After using techniques such as single-cell RNA sequencing and CyTOF technology, researchers identified for the first time a precise cell type resistant to the standard therapy for Crohn's disease, an anti-inflammatory drug called a TNF inhibitor. The drug is a major agent delivered to patients with moderate to severe Crohn's disease, however, roughly 40 percent of these patients taking the inhibitor do not respond to the therapy.

"Single-cell profiling could transform drug discovery," said co-corresponding author Miriam Merad, MD, PhD, Director of the Precision Immunology Institute at the Icahn School of Medicine at Mount Sinai, Mount Sinai Professor in Cancer Immunology, Co-Director of the Cancer Immunology Program at The Tisch Cancer Institute and Director of the Mount Sinai Human Immune Monitoring Center. "It's really going to give us much more clarity into inflammatory bowel disease and why patients are resisting and what else we could be targeting."

Discovering a signature of cells can help identify patients who fail on this therapeutic inhibitor and avoid surgical complications. The study has allowed researchers to explore new ways of developing diagnostic methods that can determine such signature through a simple blood test. If such a diagnostic method is developed, doctors can prescribe other medicines besides a TNF inhibitor that will work well for their patients.

"Our study shows that approaches that combine high-resolution single-cell mapping of inflammatory lesions in small numbers of patients with bulk RNA sequencing on large cohorts with extensive clinical characterization leads to generalizable insights, highlighting the potential to broadly transform understanding of human multifactorial immune-mediated inflammatory diseases," said co-corresponding author Ephraim Kenigsberg, PhD, Assistant Professor of Genetics and Genomic Sciences at the Icahn Institute for Data Science and Genomic Technology.

Source: Science Daily

About the Author
  • Nouran is a scientist, educator, and life-long learner with a passion for making science more communicable. When not busy in the lab isolating blood macrophages, she enjoys writing on various STEM topics.
You May Also Like
MAY 15, 2021
Drug Discovery & Development
New Weight Loss Drug Converts Energy-Storing Fat into Energy-Burning Fat
MAY 15, 2021
New Weight Loss Drug Converts Energy-Storing Fat into Energy-Burning Fat
According to the World Health Organization (WHO), in 2016, around 2 billion adults around the world were overweight ...
MAY 25, 2021
Cell & Molecular Biology
A simplified high-throughput protein expression system
MAY 25, 2021
A simplified high-throughput protein expression system
Protein synthesis, protein engineering, and synthetic biology researchers can research their protein of interest using e ...
JUN 10, 2021
Cell & Molecular Biology
Does Lithium Prevent Colon Cancer?
JUN 10, 2021
Does Lithium Prevent Colon Cancer?
Researchers found that a drug used in the treatment of mental illness can promote the fitness of healthy gut stem cells, ...
JUN 26, 2021
Cannabis Sciences
CBD Shows Promise for Lowering Blood Sugar
JUN 26, 2021
CBD Shows Promise for Lowering Blood Sugar
Whether or not cannabis can help manage symptoms of diabetes is unclear. While some studies support cannabis as a potent ...
JUL 12, 2021
Health & Medicine
Is Caffeine Good or Bad for Migraines?
JUL 12, 2021
Is Caffeine Good or Bad for Migraines?
The short answer is it's still not certain if caffeine helps or worsens migraines, but chronic consumption of caffei ...
JUL 16, 2021
Cardiology
Therapeutic Exosome Spray May One Day Aid Heart Attack Recovery
JUL 16, 2021
Therapeutic Exosome Spray May One Day Aid Heart Attack Recovery
When the flow of blood to the heart is blocked, heart cells don't get enough oxygen and begin to die; this is a heart at ...
Loading Comments...